Seizures Temporally Associated With SSRI Treatment: A Two‐Case Report Exploring Agomelatine as a Treatment Alternative
Case Reports in Psychiatry · 2026-01 · 2026 (1)
DOI: 10.1155/crps/9178274 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Psychiatry, online erschienen am 25.07.2026. Verfasst von José Alfonso Ontiveros Sanchez De La Barquera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, "Dr Jose Eleuterio Gonzalez" University Hospital, UANL, Monterrey, Nuevo Leon, Mexico, uanl.mx. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Selective serotonin reuptake inhibitors (SSRIs) are widely used as first‐line treatments for major depressive disorder (MDD) and anxiety disorders, with common adverse effects, including sexual dysfunction, anxiety, insomnia, and appetite changes, although seizures have also been reported, particularly in the presence of risk factors such as older age, family history of epilepsy, neurological comorbidities, and high antidepressant dosages. We describe two patients who developed generalized tonic–clonic seizures associated with SSRI therapy. The first case is a man with SSRI‐resistant MDD and multiple medical comorbidities who experienced five generalized tonic–clonic seizures while receiving various antidepressants. The second case is a woman with generalized anxiety disorder (GAD) who developed two generalized tonic–clonic seizures temporally related to paroxetine use. In both cases, extensive investigations, including laboratory tests, electroencephalogram (EEG), CT, and MRI, yielded normal results, suggesting a potential drug‐associated etiology. Both patients were subsequently switched to the atypical antidepressant agomelatine, which was followed by a complete cessation of seizures and marked improvement in mood and anxiety symptoms. These observations underscore the need to consider seizures as a potential adverse event of SSRIs and suggest that agomelatine could be considered an alternative pharmacological option for patients at risk of antidepressant‐associated seizures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, "Dr Jose Eleuterio Gonzalez" University Hospital, UANL, Monterrey, Nuevo Leon, Mexico, uanl.mx.
- Department of Psychiatry, "Tecnológico of Monterrey", Monterrey, Nuevo Leon, Mexico, udem.edu.mx.
- Department of Infectology, "Angeles Lindavista" Hospital, Mexico City, Mexico.
ORCID-Profile: José Alfonso Ontiveros Sanchez De La Barquera, Luis Alberto De La Garza Garcia, Guillermo Sanchez Torres, Leopoldo Iván Santacruz Torres, Arturo Alejandro Vera Vidaurri
Zitieren
APA
Sanchez De La Barquera, J. A. O., De La Garza Garcia, L. A., Sanchez Torres, G., Santacruz Torres, L. I., & Vera Vidaurri, A. A. (2026). Seizures Temporally Associated With SSRI Treatment: A Two‐Case Report Exploring Agomelatine as a Treatment Alternative. Case Reports in Psychiatry, 2026(1). https://doi.org/10.1155/crps/9178274
Vancouver
Sanchez De La Barquera JAO, De La Garza Garcia LA, Sanchez Torres G, Santacruz Torres LI, Vera Vidaurri AA. Seizures Temporally Associated With SSRI Treatment: A Two‐Case Report Exploring Agomelatine as a Treatment Alternative. Case Reports in Psychiatry. 2026;2026(1). doi:10.1155/crps/9178274
BibTeX
@article{SanchezDeLaBarquera2026,
author = {Sanchez De La Barquera, José Alfonso Ontiveros and De La Garza Garcia, Luis Alberto and Sanchez Torres, Guillermo and Santacruz Torres, Leopoldo Iván and Vera Vidaurri, Arturo Alejandro},
title = {Seizures Temporally Associated With SSRI Treatment: A Two‐Case Report Exploring Agomelatine as a Treatment Alternative},
journal = {Case Reports in Psychiatry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crps/9178274}
}
EUVIMED